首页> 外国专利> TRANSFORMING GROWTH FACTOR BETA1 / TRANSFORMING GROWTH FACTOR BETA2 HYBRID PRECURSOR AND CODING NUCLEOTID SEQUENCE FOR THEM

TRANSFORMING GROWTH FACTOR BETA1 / TRANSFORMING GROWTH FACTOR BETA2 HYBRID PRECURSOR AND CODING NUCLEOTID SEQUENCE FOR THEM

机译:转化生长因子BETA1 /转化生长因子BETA2杂交前体及其编码核苷酸序列

摘要

cDNA clones coding for TGF- beta 2 which are used to construct expression vectors capable of directing the high-level expression of mature, biologically active TGF- beta 2 in transfected Chinese Hamster Ovary cells (CHO cells) are described. The TGF- beta 2 produced and secreted by CHO transfectants has a specific activity estimated to be about half that of recombinant TGF- beta 1. The clones were isolated from a tamoxifen-treated human prostatic adenocarcinoma cell line (PC-3) using oligonucleotide probes based on the partial amino acid sequence of purified TGF- beta 2 from an African green monkey cell line, BSC-40. The cDNA sequences predict that TGF- beta 2 is synthesized as polypeptide precursor forms from which the mature 112 amino acid TGF- beta 2 subunit is derived by proteolytic cleavage. The proteins coded for by the human TGF- beta 1 and TGF- beta 2 cDNAs show an overall homology of 41%. The mature and amino- terminal precursor regions show 71% and 31% homology respectively. Northern blot analysis identified TGF- beta 2 transcripts of 4.1 kb, 5.1 kb, and 6.5 kb using mRNA from several different sources. Analysis of polyadenylated RNA from tamoxifen-treated PC-3 cells showed that these cells contain higher amounts of TGF- beta 1 transcripts than TGF- beta 2, although they produce more TGF- beta 2 protein than TDF- beta 1. This suggests that there is a post-transcriptional level of regulation for the production of these proteins.
机译:描述了编码TGF-β2的cDNA克隆,其用于构建表达载体,所述表达载体能够指导成熟的,具有生物活性的TGF-β2在转染的中国仓鼠卵巢细胞(CHO细胞)中的高水平表达。由CHO转染子产生和分泌的TGF-beta 2具有比重组TGF-beta 1大约一半的比活性。使用寡核苷酸探针从他莫昔芬治疗的人前列腺腺癌细胞系(PC-3)中分离出克隆。基于来自非洲绿猴细胞系BSC-40的纯化TGF-β2的部分氨基酸序列。 cDNA序列预测TGF-β2以多肽前体形式合成,通过蛋白水解切割从中衍生出成熟的112个氨基酸的TGF-β2亚基。人TGF-β1和TGF-β2cDNA编码的蛋白质显示41%的整体同源性。成熟的区域和氨基末端的前体区域分别显示71%和31%的同源性。 Northern印迹分析使用来自几种不同来源的mRNA鉴定了4.1 kb,5.1 kb和6.5 kb的TGF-β2转录本。他莫昔芬处理的PC-3细胞中多腺苷酸RNA的分析表明,尽管这些细胞比TDF-beta 1产生更多的TGF-beta 2蛋白,但它们包含的TGF-beta 1转录物数量要比TGF-beta 2高。是这些蛋白质生产的转录后调控水平。

著录项

  • 公开/公告号ATA245488A

    专利类型

  • 公开/公告日1994-04-15

    原文格式PDF

  • 申请/专利权人 ONCOGEN A LIMITED PARTNERSHIP;

    申请/专利号AT19880002454

  • 发明设计人

    申请日1988-10-05

  • 分类号C12N15/18;

  • 国家 AT

  • 入库时间 2022-08-22 04:43:18

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号